Executive Moves Profound Medical appoints accomplished financial executive, Murielle Lortie, to board Murielle Lortie Profound Medical (NASDAQ:PROF; TSX:PRN) appointed financial executive, Murielle Lortie, as a director, effective immediately. Ms. Lortie is the CFO of Liminal Biosciences, a Nasdaq-listed, clinical-stage... November 30, 2020